MENU
+Compare
NRXS
Stock ticker: ASE
AS OF
Apr 23 closing price
Price
$2.42
Change
+$0.47 (+24.10%)
Capitalization
14.07M

NRXS Neuraxis Forecast, Technical & Fundamental Analysis

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more

NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NRXS with price predictions
Apr 22, 2025

NRXS's RSI Indicator ascending out of oversold territory

The RSI Indicator for NRXS moved out of oversold territory on April 21, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 11 similar instances when the indicator left oversold territory. In of the 11 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 18 cases where NRXS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on NRXS as a result. In of 33 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NRXS just turned positive on April 22, 2025. Looking at past instances where NRXS's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where NRXS advanced for three days, in of 72 cases, the price rose further within the following month. The odds of a continued upward trend are .

NRXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NRXS entered a downward trend on April 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.821) is normal, around the industry mean (13.887). P/E Ratio (0.000) is within average values for comparable stocks, (63.180). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.782). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (5.023) is also within normal values, averaging (251.479).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NRXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NRXS is expected to report earnings to fall 34.78% to -15 cents per share on April 09

Neuraxis NRXS Stock Earnings Reports
Q4'23
Est.
$-0.15
Q4'24
Missed
by $0.27
Q1'24
Missed
by $0.22
Q3'23
Missed
by $1.18
The last earnings report on March 20 showed earnings per share of -23 cents, missing the estimate of 3 cents. With 69.03K shares outstanding, the current market capitalization sits at 14.07M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYGR3.480.11
+3.26%
Voyager Therapeutics
BAH115.133.18
+2.84%
Booz Allen Hamilton Holding Corp
BDN3.970.08
+2.06%
Brandywine Realty Trust
SPT19.510.20
+1.04%
Sprout Social
BLIN1.52N/A
N/A
Bridgeline Digital

NRXS and Stocks

Correlation & Price change

A.I.dvisor tells us that NRXS and NGNE have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRXS and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+8.64%
NGNE - NRXS
24%
Poorly correlated
+15.06%
TCRT - NRXS
23%
Poorly correlated
+2.13%
ESLA - NRXS
22%
Poorly correlated
+5.65%
VTYX - NRXS
21%
Poorly correlated
+4.42%
CLGN - NRXS
21%
Poorly correlated
-5.53%
More